Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III Definition of the Metabolic Syndrome

Abstract

Results from a population-based survey O ur objective was to evaluate the diagnostic proficiency of the World Health Organization (WHO) and the National Cholesterol Education Program (NCEP)-III definitions (1,2) for the metabolic syndrome in a Mexican nationwide, population-based survey. Details of the sampling procedures have been previously described (3). The population was composed of 2,158 men and women aged 20 -69 years sampled after a 9-to 12-h fasting period. For the WHO criteria, insulin resistance was diagnosed if a nondiabetic case had fasting insulin concentrations Ն126 pmol/l (21 U/ml) (Ͼ75th percentile in Mexican adults). The ageadjusted prevalence was 13.61% for the WHO criteria (n ϭ 268) and 26.6% for the NCEP-III definition (n ϭ 574). After excluding patients with diabetes, the prevalence was 9.2 and 21.4%, respectively. The agreement between the definitions was assessed in 1,969 subjects; 189 cases were eliminated due to the lack of a urine sample.The number of abnormal cases was lower using the WHO criteria. Only 237 of the 545 subjects (43.4%) who fulfilled the NCEP criteria were diagnosed as affected using the WHO definition. Just 16 of 253 cases (6.3%) detected by the WHO definition did not fulfill the NCEP definition. The agreement between the criteria was moderate ( ϭ 0.507). On the other hand, the subjects diagnosed using the WHO recommendations had a worse profile than the cases detected by the NCEP-III definition only-they had a higher BMI and higher non-HDL cholesterol, triglyceride, and glucose concentrations. The demonstration of insulin resistance among the nondiabetic population caused the lack of agreement in 202 of the 242 cases that fulfilled the NCEP definition but failed the WHO criteria. Other reasons for disparity were the higher thresholds used by the WHO criteria; these differences explained the lack of agreement in 66 of the 152 cases with diabetes.In conclusion, the prevalence of the metabolic syndrome is influenced by the selection of the diagnostic criteria. The WHO criteria identified a lower number of cases than the NCEP-III definition. These differences were explained mainly by the inclusion of abnormally high insulin concentrations as a diagnostic criterion. However, the presence of insulin resistance may help to identify patients more severely affected (4). We had previously assessed the effect of complete blockade of the renin-angiotensin system (RAS) in patients with advanced diabetic nephropathy (type 2 diabetes) and severe proteinuria (2). To do so, we studied 10 patients on prior treatment with ACE inhibitors at recommended doses, to which 50 mg/day of Losartan was added. CARLOS A. AGUILAR-SALINASAfter 3 months of the combined therapy, urinary protein excretion decreased from a mean of 6.9 (95% CI 4.3-9.6) to 5.8 g/24 h (3-8.6) (P ϭ 0.025) and, with the exception of two patients, was reduced in all cases. The proteinuria/ urinary creatinine ratio also decreased from 7.6 (4.2-11.05) to 6.0 g/g (3.2-8.7) (P ϭ 0.02). In one patient in which proteinuria did not ...

The Efficacy of Adipokines and Indices of Metabolic Syndrome as Predictors of Severe Obesity-Related Hepatic Steatosis

“…In general, the prevalence is 23.7%, although it varies widely between populations [42] up to 58.3% in Mexican-American women aged between 40 and 74 years [43]. Recently, the prevalence of metabolic syndrome in the Mexican population was estimated according to NCEP-III criteria to be 26.6% [44].…”

Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada

“…13 Both the World Health Organization (WHO) and the National Cholesterol Education Program (NCEP) Adult Treatment Panel III have published working definitions of the MetS, [14][15][16][17] and the prevalence rates of the MetS have been assessed in various populations around the world. [18][19][20][21][22][23][24][25][26][27][28][29][30][31] However, little is known about the distribution of MetS among Aboriginal Canadians. The aim of this study was to estimate the prevalence of MetS and describe its characteristics between two Canadian Aboriginal groups (Native Indians and Inuit) compared to non-Aboriginal Canadians of predominantly European origin.…”

Prevalence of metabolic syndrome and its association with educational inequalities among Brazilian adults: a population-based study

“…In Latin America, the prevalence of MS among adults ranges from 20 to 50% depending on the age group, gender and particular characteristics of the population studied (18,19,24,25). In Brazil, data from most epidemiological studies are restricted to specific population groups (20,(26)(27)(28)(29)(30), a fact that impairs comparisons.…”

“…However, population-based studies are still scarce in developing countries and in South America, especially in Brazil, the most populous country of the continent (18)(19)(20)(21). Moreover, the impact of the use of different definitions of MS and cut-off points for MS components to estimate the preva- …”